7/27/2019 Bangladesh Short Report
1/3
BangladeshFilariasisEliminationProgramme
SummaryReportforCentreofNeglectedTropicalDiseases,Liverpool,UK
7/27/2019 Bangladesh Short Report
2/3
IntroductionandRationaleIn Bangladesh, the disease is present all over the country with highest endemicity in
northernpartsofthecountry.
Outof147millionpeople,about20millionpeopleinthearea
has been suffering from the disease, most of which are children. The exact figures of
filariasisinBangladesharenotknown,butitisendemicin33districtsoutof64districtsas
reveledby
ICT
by
LQAS,
completed
in
2002
and
2004.
There
is
high
endemicity
of
filarisis
in
Nilphamari, Thakurgaon, Dinajpur, Rangpur, Panchagarh, Kurigram, Gaibandha, Chapai
Nawabganj, Rajshahi and Lalmonirhat. It is estimated that about 70 million are at risk of
infection, while 10 million havevarious formsofclinicaldeformityandanother10 million
aremicrofilaremics.
The introduction in recent years of yearly safe single dose regimens with DEC alone or in
combinationwithAlbendazoleforsuccessive46yearshasbeenanimportantbreakthrough
in filariasis elimination as a public health problem. The global strategy for elimination of
lymphatic filariasis is now principally based on annual single dose treatment of all the
eligible
members
of
at
risk
endemic
communities.
The
challenges
to
reach
adequate
treatment coverage and sustain drug delivery to all high risk communities are difficult to
achievebythehealthservicesalone.Theseservicesareoftenhavelittleinvolvementinthe
treatmentprogrammes.
ObjectivesGeneralObjectiveTo determine the mass drug administration coverage status and the nature of drug
reactionsinthestudyareawithaviewtoinformthefindingstotheconcernedauthorityto
takenecessarysteps.
SpecificObjectives1) TofindouttheMDAcoveragestatusamongsamplesofthestudyarea.2) To identify the nature of drug reactions with duration due to MDA among the
studysamples.
3) Tofindoutthecausesofnottakingtheantifilarialdrugsamongstudysamples.KeyVariables
1. Ageofhouseholdmembers2. Sexofthehouseholds3. Ingestionofdrugs4. Causesofnottakingdrugs5. Observedcoverage6. Actualcoverage7. Typeofdrugreactions8. Durationofdrugreaction
7/27/2019 Bangladesh Short Report
3/3
MassDrugAdministration Year No.Districts Coverage
2001 1 93%
2002 4 87.32%
2003
6
81.9%
2004 9 Nodata
2005 12 81.9%
2006 13
MDAinLalmonirhatandNilphamaridistrict,2008NameofDistrict Upazila/Paurasava Total
population
Targetedpopulation
ReportedcoverageMDA*
Lalmonirhat LalmonirhatSadar 280,495 275,705 275,723Aditmari 236296 219,455 219,455
Kaliganj
260,006 243,456 243,456
Hatibandha 246,150 227,557 226,555
Patgram 230,342 211,912 211,870
Pourashava 58,795 56,562 55,923 Total 1,312,084 1,234,647 1,232,982Nilphamari NilphamariSadar&
Paurasava
436,296 406,000 406,000
Sayedpur 285,768 260,051 258,970
Dimla 290,569 275,945 275,984
Domar 249,336 230,213 229,030
Joldhaka
335,427 301,885 300,795Kishoreganj 270,327 248,422 248,222 Total 1,867,723 1,722,516 1,719,001
SummaryA total of 3,179,807 people were covered in the 7
th round of MDA in both districts,
Lalmonirhat and Nilphamari. The MDA was undertaken in both areas for a period of 10
consecutivedays.LalmonirhatDistrictThe survey findings of Lalmonirhat district showed that the observed coverage status of
massdrugadministrationwas87%andtheactualcoveragewas91.6%amongeligible.The
reportedcoveragebyCivilSurgeonwas93.96%.
NilphamariDistrictThefindingsinNilphamaridistrictshowedthattheobservedcoverageandactualcoverage
was85.5%and88.5%respectivelyamongeligiblepopulation.ThereportedcoveragebyCivil
Surgeonwas92.04%.
Top Related